Diazepam as a treatment for metronidazole toxicosis in dogs: A retrospective study of 21 cases

被引:0
作者
Evans, J
Levesque, D
Knowles, K
Longshore, R
Plummer, S
机构
[1] Vet Neurol Ctr, Las Vegas, NV 89108 USA
[2] Vet Neurol Ctr, Phoenix, AZ USA
关键词
benzodiazepine; cerebellar disease; drug toxicity; gamma-aminobutyric acid; vestibular syndrome; PHARMACOLOGY; CATS; FLUMAZENIL; ANIMALS;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The currently recommended treatment for metronidazole toxicosis is drug discontinuation and supportive therapy. Reported recovery times are 1-2 weeks. The records of 21 dogs with metronidazole toxicosis were retrospectively analyzed to determine whether diazepam improved recovery. The dosage and duration of metronidazole therapy and the response and recovery times of 13 dogs treated with diazepam were compared to those of 8 dogs receiving only supportive care. Response time was defined as the time to resolution of the debilitating clinical signs. Recovery time was the time to resolution of all residual clinical signs. The average dosage and duration of metronidazole administration for the diazepam-treated and untreated groups were 60.3 mg/kg/d for 44.9 days and 65.1 mg/kg/d for 37.25 days. The protocol for diazepam administration consisted of an initial IV bolus and then diazepam PO q8h for 3 days. The average dosage of both the IV and PO diazepam was 0.43 mg/kg. The average response time for the diazepam-treated dogs was 13.4 hours compared to 4.25 days for the untreated group. Recovery time also was markedly shorter for the diazepam-treated dogs (38.8 hours) compared to the untreated group (I I days). Results of this study showed that dogs with metronidazole toxicosis recover faster when treated with diazepam. Although the mechanism of metronidazole toxicosis or how diazepam exerts its favorable effect is not known; it is likely related to modulation of the gamma-aminobutyric acid (GABA) receptor within the cerebellar and vestibular systems.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 52 条
[1]  
BARMACK NH, 1980, NEUROSCI LETT, V16, P33
[2]  
Bloom F.E., 1996, PHARMACOL BASIS THER, P267
[3]   MULTIPLE GABA(B) RECEPTORS [J].
BONANNO, G ;
RAITERI, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :259-261
[4]   GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[5]   FLUMAZENIL - A PRELIMINARY REVIEW OF ITS BENZODIAZEPINE ANTAGONIST PROPERTIES, INTRINSIC ACTIVITY AND THERAPEUTIC USE [J].
BROGDEN, RN ;
GOA, KL .
DRUGS, 1988, 35 (04) :448-467
[6]   GABA-A RECEPTOR SUBTYPES - FROM PHARMACOLOGY TO MOLECULAR-BIOLOGY [J].
BURT, DR ;
KAMATCHI, GL .
FASEB JOURNAL, 1991, 5 (14) :2916-2923
[7]   Metronidazole neurotoxicosis in two cats [J].
Caylor, KB ;
Cassimatis, MK .
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2001, 37 (03) :258-262
[8]   GAMMA-AMINOBUTYRIC ACID PATHWAYS IN THE CEREBELLUM STUDIED BY RETROGRADE AND ANTEROGRADE TRANSPORT OF GLUTAMIC-ACID DECARBOXYLASE ANTIBODY AFTER INVIVO INJECTIONS [J].
CHANPALAY, V ;
PALAY, SL ;
WU, JY .
ANATOMY AND EMBRYOLOGY, 1979, 157 (01) :1-14
[9]  
COCHRANE SM, 1997, 5 MINUTE VET CONSULT, P1150
[10]   MECLIZINE AND PLACEBO IN TREATING VERTIGO OF VESTIBULAR ORIGIN - RELATIVE EFFICACY IN A DOUBLE-BLIND STUDY [J].
COHEN, B ;
VIANNEYD.JM .
ARCHIVES OF NEUROLOGY, 1972, 27 (02) :129-&